Kuehne + Nagel invests in new European overland pharma fleet

  • Share on Facebook
  • Share on Twitter
  • Share on Linkedin
  • Share on Pinterest
  • Share on Blogger

Sep 05, 2018: In order to be well equipped for the peak season, Kuehne+Nagel is investing in its European Pharma fleet to strengthen the KN PharmaChain overland service in the region.

The supply chain giant has deployed 35 new pharma trailers and before end of the year another 45 will be added to the existing fleet. Also, it plans to add another 200 trailers to its fleet in the coming years.

By enlarging its own dedicated trailer fleet of standardised Schmitz Cargobull Chassis with Thermoking cooling units (mono, bi-temp and double-deck equipment), Kuehne + Nagel aims at facilitating seamless services for active temperature-controlled FTL and LTL shipments across Europe.

The overland pharma fleet is part of the KN PharmaChain network, providing multimodal GxP compliant door-to-door shipping on a global scale, enhanced visibility and traceability of the deliveries, as well as intensive and proactive risk management and integrated warehousing services.

Uwe Hott, senior vice president Overland Europe at Kuehne + Nagel: “Logistics solutions for the pharma and healthcare industry are among the most important growth drivers for Kuehne + Nagel’s overland and regional business.”

The new pharma trailers are fully GxP compliant and offer state-of-the-art technology for temperature controlled transports, including dual temperature, double-deck equipment, TAPA (Transport Asset Protection Association) compliant integrated security locks to be opened remotely with a unique code, integrated control panel, printer for temperature report and GPS control for positioning, temperature, door sensors, coupling and technical status.

  • Share on Facebook
  • Share on Twitter
  • Share on Linkedin
  • Share on Pinterest
  • Share on Blogger